{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:05:40Z","timestamp":1762459540048},"reference-count":32,"publisher":"Medwave Estudios Limitada","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medwave"],"DOI":"10.5867\/medwave.2017.09.7117","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T16:10:39Z","timestamp":1514563839000},"page":"e7117-e7117","source":"Crossref","is-referenced-by-count":3,"title":["Is pre-exposure prophylaxis effective for preventing HIV infection in men who have sex with men?"],"prefix":"10.5867","volume":"17","author":[{"given":"Rub\u00e9n","family":"Allende","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Paz","family":"Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3888","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"issue":"12","key":"ref0","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Effectiveness and safety of oral HIV preexposure prophylaxis for all populations.","volume":"30","author":"Fonner","year":"2016","unstructured":"Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O'Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016 Jul;30(12):1973\u201383.","journal-title":"AIDS","ISSN":"http:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref1","article-title":"Does Pre-exposure prophylaxis (PrEP) for HIV prevention in men who have sex with men (MSM) change risk behavior? A systematic review.","author":"Freeborn","year":"2017","unstructured":"Freeborn K, Portillo CJ. Does Pre-exposure prophylaxis (PrEP) for HIV prevention in men who have sex with men (MSM) change risk behavior? A systematic review. J Clin Nurs. 2017 Aug.","journal-title":"J Clin Nurs","ISSN":"http:\/\/id.crossref.org\/issn\/0962-1067","issn-type":"print"},{"issue":"2","key":"ref2","doi-asserted-by":"publisher","first-page":"e87674","DOI":"10.1371\/journal.pone.0087674","article-title":"Pre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trials.","volume":"9","author":"Jiang","year":"2014","unstructured":"Jiang J, Yang X, Ye L, Zhou B, Ning C, Huang J, et al. Pre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trials. PLoS One. 2014;9(2):e87674.","journal-title":"PLoS One","ISSN":"http:\/\/id.crossref.org\/issn\/1932-6203","issn-type":"print"},{"key":"ref3","unstructured":"Kennedy CE, Fonner VA, World Health Organization. Pre-exposure prophylaxis for men who have sex with men: a systematic review. 2014."},{"issue":"7","key":"ref4","first-page":"CD007189","article-title":"Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.","author":"Okwundu","year":"2012","unstructured":"Okwundu CI, Uthman OA, Okoromah CA. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane database Syst Rev. 2012 Jul;(7):CD007189.","journal-title":"Cochrane Database Syst Rev","ISSN":"http:\/\/id.crossref.org\/issn\/1469-493X","issn-type":"print"},{"issue":"1","key":"ref5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/21691401.2014.934458","article-title":"Pre-exposure prophylaxis of HIV: A right way to go or a long way to go","volume":"44","author":"Yu","year":"2016","unstructured":"Yu W, Wang L, Han N, Zhang X, Mahapatra T, Mahapatra S, et al. Pre-exposure prophylaxis of HIV: A right way to go or a long way to go? Artif cells, nanomedicine, Biotechnol. 2016;44(1):201\u20138.","journal-title":"Artif cells nanomedicine Biotechnol"},{"issue":"5","key":"ref6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/QAI.0000000000000216","article-title":"Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection.","volume":"66","author":"Amico","year":"2014","unstructured":"Amico KR, Marcus JL, McMahan V, Liu A, Koester KA, Goicochea P, et al. Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection. J Acquir Immune Defic Syndr. 2014 Aug;66(5):530\u20137.","journal-title":"J Acquir Immune Defic Syndr","ISSN":"http:\/\/id.crossref.org\/issn\/1525-4135","issn-type":"print"},{"issue":"6","key":"ref7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S1473-3099(14)70025-8","article-title":"HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.","volume":"14","author":"Buchbinder","year":"2014","unstructured":"Buchbinder SP, Glidden D V, Liu AY, McMahan V, Guanira J V, Mayer KH, et al. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial. Lancet Infect Dis. 2014 Jun;14(6):468\u201375.","journal-title":"Lancet Infect Dis","ISSN":"http:\/\/id.crossref.org\/issn\/1473-3099","issn-type":"print"},{"issue":"7","key":"ref8","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10461-015-1055-5","article-title":"Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes.","volume":"20","author":"Carlo Hojilla","year":"2016","unstructured":"Carlo Hojilla J, Koester KA, Cohen SE, Buchbinder S, Ladzekpo D, Matheson T, et al. Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes. AIDS Behav. 2016 Jul;20(7):1461\u20139.","journal-title":"AIDS Behav","ISSN":"http:\/\/id.crossref.org\/issn\/1090-7165","issn-type":"print"},{"issue":"5","key":"ref9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/QAI.0b013e3181e19a54","article-title":"Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men.","volume":"54","author":"Golub","year":"2010","unstructured":"Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr. 2010 Aug;54(5):548\u201355.","journal-title":"J Acquir Immune Defic Syndr","ISSN":"http:\/\/id.crossref.org\/issn\/1525-4135","issn-type":"print"},{"issue":"27","key":"ref10","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec;363(27):2587\u201399.","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"9","key":"ref11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.","volume":"14","author":"Grant","year":"2014","unstructured":"Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014 Sep;14(9):820\u20139.","journal-title":"Lancet Infect Dis","ISSN":"http:\/\/id.crossref.org\/issn\/1473-3099","issn-type":"print"},{"issue":"7","key":"ref12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1089\/apc.2014.0315","article-title":"Attitudes Towards PrEP and Anticipated Condom Use Among Concordant HIV-Negative and HIV-Discordant Male Couples.","volume":"29","author":"Hoff","year":"2015","unstructured":"Hoff CC, Chakravarty D, Bircher AE, Campbell CK, Grisham K, Neilands TB, et al. Attitudes Towards PrEP and Anticipated Condom Use Among Concordant HIV-Negative and HIV-Discordant Male Couples. AIDS Patient Care STDS. 2015 Jul;29(7):408\u201317.","journal-title":"AIDS Patient Care STDS","ISSN":"http:\/\/id.crossref.org\/issn\/1087-2914","issn-type":"print"},{"issue":"4","key":"ref13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/QAI.0b013e3182801081","article-title":"The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.","volume":"62","author":"Hosek","year":"2013","unstructured":"Hosek SG, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, et al. The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men. J Acquir Immune Defic Syndr. 2013 Apr;62(4):447\u201356.","journal-title":"J Acquir Immune Defic Syndr","ISSN":"http:\/\/id.crossref.org\/issn\/1525-4135","issn-type":"print"},{"issue":"8","key":"ref14","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/infdis\/jiu233","article-title":"HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial.","volume":"210","author":"Liegler","year":"2014","unstructured":"Liegler T, Abdel-Mohsen M, Bentley LG, Atchison R, Schmidt T, Javier J, et al. HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial. J Infect Dis. 2014 Oct;210(8):1217\u201327.","journal-title":"J Infect Dis","ISSN":"http:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"issue":"5","key":"ref15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/QAI.0000000000000351","article-title":"Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study.","volume":"67","author":"Liu","year":"2014","unstructured":"Liu A, Glidden D V, Anderson PL, Amico KR, McMahan V, Mehrotra M, et al. Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study. J Acquir Immune Defic Syndr. 2014 Dec;67(5):528\u201337.","journal-title":"J Acquir Immune Defic Syndr","ISSN":"http:\/\/id.crossref.org\/issn\/1525-4135","issn-type":"print"},{"issue":"1","key":"ref16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","article-title":"Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.","volume":"176","author":"Liu","year":"2016","unstructured":"Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, et al. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services. JAMA Intern Med. 2016 Jan;176(1):75\u201384.","journal-title":"JAMA Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/2168-6106","issn-type":"print"},{"issue":"12","key":"ref17","doi-asserted-by":"publisher","first-page":"e81997","DOI":"10.1371\/journal.pone.0081997","article-title":"No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis.","volume":"8","author":"Marcus","year":"2013","unstructured":"Marcus JL, Glidden D V, Mayer KH, Liu AY, Buchbinder SP, Amico KR, et al. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One. 2013;8(12):e81997.","journal-title":"PLoS One","ISSN":"http:\/\/id.crossref.org\/issn\/1932-6203","issn-type":"print"},{"key":"ref18","volume-title":"Pragmatic open-label randomised trial of preexposure prophylaxis","author":"McCormack","year":"2015","unstructured":"McCormack S, Dunn DT. Pragmatic open-label randomised trial of preexposure prophylaxis: The PROUD Study. In: CROI. Seattle, Washington; 2015."},{"issue":"10013","key":"ref19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.","volume":"387","author":"McCormack","year":"2016","unstructured":"McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet (London, England). 2016 Jan;387(10013):53\u201360.","journal-title":"Lancet (London England)"},{"issue":"6","key":"ref20","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/QAD.0000000000000156","article-title":"Changes in renal function associated with oral emtricitabine\/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis.","volume":"28","author":"Solomon","year":"2014","unstructured":"Solomon MM, Lama JR, Glidden D V, Mulligan K, McMahan V, Liu AY, et al. Changes in renal function associated with oral emtricitabine\/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. AIDS. 2014 Mar;28(6):851\u20139.","journal-title":"AIDS","ISSN":"http:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"issue":"10","key":"ref21","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/cid\/civ778","article-title":"No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.","volume":"61","author":"Volk","year":"2015","unstructured":"Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, et al. No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting. Clin Infect Dis. 2015 Nov;61(10):1601\u20133.","journal-title":"Clin Infect Dis","ISSN":"http:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"issue":"23","key":"ref22","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.","volume":"373","author":"Molina","year":"2015","unstructured":"Molina J-M, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 2015 Dec;373(23):2237\u201346.","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref23","volume-title":"On demand PrEP with oral TDF-FTC in MSM","author":"Molina","year":"2015","unstructured":"Molina J-M, Capitant C, Charreau I. On demand PrEP with oral TDF-FTC in MSM: Results of the ANRS Ipergay Trial. In: CROI. Seattle, Washington; 2015."},{"issue":"1","key":"ref24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/QAI.0b013e31828ece33","article-title":"Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.","volume":"64","author":"Grohskopf","year":"2013","unstructured":"Grohskopf LA, Chillag KL, Gvetadze R, Liu AY, Thompson M, Mayer KH, et al. Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2013 Sep;64(1):79\u201386.","journal-title":"J Acquir Immune Defic Syndr","ISSN":"http:\/\/id.crossref.org\/issn\/1525-4135","issn-type":"print"},{"key":"ref25","volume-title":"Validating measures of tenofovir drug exposure in a U S pre-exposure prophylaxis trial","author":"Liu","year":"2015","unstructured":"Liu AY, Vittinghoff E, Gandhi M, Huang Y, Chillag K, Wiegand R. Validating measures of tenofovir drug exposure in a U.S. pre-exposure prophylaxis trial. In: CROI. Seattle, Washington; 2015."},{"issue":"1","key":"ref26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/QAI.0b013e31828f097a","article-title":"Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States.","volume":"64","author":"Liu","year":"2013","unstructured":"Liu AY, Vittinghoff E, Chillag K, Mayer K, Thompson M, Grohskopf L, et al. Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States. J Acquir Immune Defic Syndr. 2013 Sep;64(1):87\u201394.","journal-title":"J Acquir Immune Defic Syndr","ISSN":"http:\/\/id.crossref.org\/issn\/1525-4135","issn-type":"print"},{"issue":"8","key":"ref27","doi-asserted-by":"publisher","first-page":"e23688","DOI":"10.1371\/journal.pone.0023688","article-title":"Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco.","volume":"6","author":"Liu","year":"2011","unstructured":"Liu AY, Vittinghoff E, Sellmeyer DE, Irvin R, Mulligan K, Mayer K, et al. Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. PLoS One. 2011;6(8):e23688.","journal-title":"PLoS One","ISSN":"http:\/\/id.crossref.org\/issn\/1932-6203","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, et al. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS One. 2012;7(4):e33103. Food and Drug Administration. First Generic Drug Approvals [Internet]. 2017 [cited 2017 Dec 10]. | Link | Centers for Disease Control and Prevention. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States [Internet]. 2014. | Link |","DOI":"10.1371\/journal.pone.0033103"},{"key":"ref29","volume-title":"WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection","year":"2017","unstructured":"World Health Organization. WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection [Internet]. 2017. | Link |"},{"key":"ref30","unstructured":"U.S. Preventive Services Task Force. Draft Update Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Pre-Exposure Prophylaxis [Internet]. 2017 [cited 2017 Jan 12]. | Link | Gilead Sciences. Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F\/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection (DISCOVER) [Internet]. Report No.: NCT02842086. | Link | National Institute of Allergy and Infectious Diseases. Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate\/Emtricitabine (TDF\/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men [Internet]. Report No.: NCT02720094. | Link | Murchu EO. Systematic review of the clinical effectiveness and cost-effectiveness of various dosing schedules of pre-exposure prophylaxis (PrEP) for the prevention of HIV in males who have sex with males (MSM). [Internet]. Report No.: CRD42017065937. | Link |"},{"key":"ref31","unstructured":"Thavorn K, Mishra S, Tan D, Kugathasan H, Moqueet N, McFadden D. Cost-effectiveness of HIV Pre-exposure Prophylaxis (PrEP) strategies: a methodological systematic review [Internet]. Report No.: CRD42016038440. | Link | Traeger M, Schr\u00f6der S, Doyle J, Stoov\u00e9 M. Effects of pre-exposure prophylaxis (PrEP) on sexual risk taking behaviour in men who have sex with men: a systematic review and meta-analysis. Report No.: CRD42017059674. Baranek B, Wang S, Cheung A, Mishra S, Tan D. A systematic review and meta-analysis of the effect of oral tenofovir disoproxil fumarate-containing HIV pre-exposure prophylaxis on bone mineral density [Internet]. Report No.: CRD42017070552. | Link |"}],"container-title":["Medwave"],"original-title":["\u00bfEs efectiva la profilaxis pre-exposici\u00f3n para prevenir infecci\u00f3n por VIH en hombres que tienen sexo con hombres?"],"link":[{"URL":"https:\/\/www.medwave.cl\/link.cgi\/Medwave\/PuestaDia\/ResEpis\/7117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T21:17:06Z","timestamp":1570569426000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medwave.cl\/link.cgi\/Medwave\/PuestaDia\/ResEpis\/7117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,29]]},"references-count":32,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2017,12,29]]}},"URL":"https:\/\/doi.org\/10.5867\/medwave.2017.09.7117","relation":{},"ISSN":["0717-6384"],"issn-type":[{"value":"0717-6384","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,29]]}}}